As of Jun 27
| -4.00 / -9.04%|
The 7 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 62.00, with a high estimate of 90.00 and a low estimate of 46.00. The median estimate represents a +53.96% increase from the last price of 40.27.
The current consensus among 8 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since June, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.